(PharmaNewsWire.Com, May 12, 2017 ) According to the report Global Diabetic Retinopathy Market, published by Market Data Forecast, the global market projected to reach USD 8.52 billion by 2021, at a CAGR of 6.9% from 2016 to 2021.
Diabetes is a long-lasting disorder associated with defects in the secretion of insulin from the hyperglycaemia or pancreas associated to insulin resistance which eventually leads to long term multi-organ complications of nerves, kidneys, eye, blood vessels, and heart.
The most severe and common sight threatening complication of diabetes is Diabetic Retinopathy (DR) which leads to damaging of the blood vessels present in the retina of the eye. The treatment procedure of diabetic retinopathy depends on the various stages of diabetic retinopathy. It is one of the most dominant reasons of blindness in adults globally.
The rising incidence of diabetes coupled with growing prevalence of blindness due to diabetes is expected to drive market growth over the forecast period. Raising global geriatric population prevalence and strong awareness for early detection of diabetic retinopathy will be vital factors for driving global diabetic retinopathy market demand. However, dearth of skilled ophthalmologist combined with poor primary infrastructure is expected to constrain the market growth.
The products are segmented based on Type of Treatment, Indication and End Users and studied for a deep-level understanding of the Diabetic Retinopathy Market. Each sub-segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Based on Type of Treatment: Anti-Vascular Endothelial Growth Factor (VEGF) drug Intraocular Steroid Injection Laser Surgery Vitrectomy
Based on Indication: Non-Proliferative Diabetic Retinopathy (NPDR) o Mild o Moderate o Severe Proliferative Diabetic Retinopathy (PDR)
Based on End Users: Hospitals Ophthalmic Clinics Ambulatory Surgical Centers
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. North America dominated the market followed by Asia-Pacific and Europe. The factors attributable for North America are having high obesity rates while Europe has large population of baby boomers. The emerging nations of Asia Pacific such as China and India are anticipated to witness significant growth during the forecast period owing to increasing disposable income, innovation in diagnostics, expanding geriatric population base, rising research funding for diabetes and a large pool of patients.
Geographical Segmentation: North America Diabetic Retinopathy Market Europe Diabetic Retinopathy Market Asia-pacific Diabetic Retinopathy Market Latin America Diabetic Retinopathy Market The Middle East and Africa Diabetic Retinopathy Market
The key players in Global Diabetic Retinopathy Market are Abbott Laboratories Inc., Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Valeant Pharmaceutical International Inc., Regeneron Pharmaceutical Inc., Novartis AG, Alimera Science Inc. and Ampio Pharmaceuticals Inc.
Further, technological breakthroughs in retinal screening methods and equipment like utilization of slit lamps and launching of new products like Gly-230 & Optima are the drivers predicted to drive the industry expansion. Increasing occurrence of diabetes predicted to affect more than 4.6% of world population will also improve the industry growth.
The Diabetic Retinopathy Market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of Type of Treatment, Indication and End Users along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
